Epithelial mapping — sometimes called epithelial thickness mapping, or ETM — is one of the newer diagnostic tools that has quietly changed LASIK candidacy screening over the last decade. If you're being screened at a Colombian LASIK clinic in 2026 and epithelial mapping isn't part of the workup, you're getting screening from a decade ago. Here's what it does, why it matters, and what the resulting map actually shows.
What the epithelium is (and why it matters)
The cornea has three main structural layers: the outer epithelium (about 50 microns thick), the middle stroma (about 500 microns, containing the collagen fibers that give the cornea its shape and strength), and the inner endothelium plus supporting layers.
For LASIK, the stroma is what actually gets reshaped by the laser. Traditional candidacy screening — corneal topography, pachymetry, refractive measurements — focuses on stromal thickness and shape because those determine how much laser correction can be safely performed.
The wrinkle: the epithelium is not uniform. It thickens and thins across the surface of the cornea in patterns that don't show up on standard topography. And those patterns matter for LASIK safety in ways that only recently became measurable.
The keratoconus problem epithelial mapping solves
Keratoconus is a progressive corneal disorder where the stroma thins and bulges asymmetrically. Advanced keratoconus is obvious on any decent screening — the topography shows the classic bulge, corneal thickness is dramatically reduced. Advanced keratoconus is a firm LASIK disqualification.
The problem is early or subclinical keratoconus — cases where the stromal changes have begun but haven't yet produced obvious topography abnormalities. If a subclinical keratoconus patient gets LASIK, the surgery accelerates the disease. The resulting progressive vision loss is one of the most feared and most preventable LASIK complications.
Here's the key insight: the epithelium camouflages early keratoconus. Where the stroma thins abnormally, the epithelium compensates by thickening in the same location, smoothing out the surface curvature and hiding the underlying problem from standard topography. But if you can measure epithelial thickness directly at hundreds of points across the cornea, you can see the compensation pattern — and unmask the underlying stromal issue.
That's exactly what epithelial mapping does.
How the measurement works
Modern epithelial mapping is performed by anterior-segment optical coherence tomography (OCT). The scan is fast (under a minute), non-contact (no dye, no anesthetic), and produces a color-coded map of epithelial thickness at hundreds or thousands of individual points across the corneal surface.
Common platforms in Colombian clinics include the Optovue Avanti/iOptics and the Zeiss Cirrus HD-OCT. Both produce comparable-quality maps; the important thing is that the platform includes an anterior-segment scan mode with epithelial thickness measurement.
Reading the map: what patterns mean
Normal epithelium
A healthy epithelium is roughly uniform across the central cornea, with slight thickening at the periphery. On a color-coded map, this shows as a smooth central plateau with gentle peripheral variation. Nothing dramatic; nothing asymmetric.
The "donut" or "epithelial ring" pattern
Classic subclinical keratoconus produces a distinctive pattern: thinning centrally over the region of stromal abnormality, surrounded by a ring of thickening. The map looks like a donut or bullseye. Depending on the severity, this pattern rules out LASIK entirely or triggers a series of follow-up tests including corneal biomechanics (Corvis-ST or ORA), Scheimpflug tomography (Pentacam), and often referral for potential cross-linking rather than laser vision correction.
Asymmetric focal thinning
Localized thin spots that don't fit the donut pattern can indicate other issues: dry-eye related epithelial breakdown, previous inflammation, contact lens-related epithelial changes, or early ectatic changes. Each requires interpretation in context.
Asymmetric thickening
Focal thickening without matching thinning can indicate epithelial hyperplasia — often from chronic contact lens wear or subclinical dry eye. Not usually a LASIK dealbreaker but often a trigger for pre-op dry eye treatment before proceeding.
What epithelial mapping doesn't do
- It doesn't replace corneal topography or tomography. It's a complementary test.
- It doesn't diagnose disease on its own. It flags patterns for further evaluation.
- It doesn't provide biomechanical information (that's what Corvis-ST and ORA are for).
- It's not necessary for every patient. Most healthy candidates with clean topography don't have hidden findings on epithelial mapping. But you can't know that without the test.
What to ask your Colombian clinic
When you're evaluating clinics, these are the concrete screening questions worth asking directly:
- Does your standard pre-op screening include epithelial thickness mapping? (If no, that's a filter.)
- What platform do you use? (OCT-based platforms are current standard; some older screening protocols used only topography.)
- Is the ETM interpretation done by the surgeon, or by an outside imaging center? (Surgeon-interpreted is preferred for LASIK candidacy decisions.)
- If ETM shows a suspicious pattern, what additional testing do you order? (Good answers include Pentacam tomography, Corvis-ST biomechanics, and if warranted, delayed follow-up to check for progression.)
Any clinic that consistently clears everyone for LASIK is either not screening thoroughly or not honestly reporting borderline findings. Approximately 15-20% of patients presenting for LASIK screening in most published series have some finding that either disqualifies them or shifts them to an alternative procedure (PRK, ICL, RLE). If a clinic's ETM findings never seem to disqualify anyone, ask why — you're almost certainly seeing rushed or skipped screening.
Where Colombia sits in screening technology
Top-tier LASIK clinics in Medellín and Bogotá typically operate current-generation screening platforms — the same equipment you'd see at premium clinics in Miami or Madrid. The technology has become widely available, and Colombian medical tourism competition has pushed most competitive clinics to invest in modern imaging. That said, technology alone doesn't equal quality: the surgeon's interpretation of findings and willingness to disqualify borderline candidates matters more than the specific machine model. Screen for both.